OTHER PROTEIN KINASE INHIBITORS IN ATC
- avapritinib (AYVAKYT)
- cabozantinib (cabozantinib malate) (CABOMETYX)
- capivasertib (TRUQAP)
- entrectinib (ROZLYTREK)
- gilteritinib (gilteritinib fumarate) (XOSPATA)
- larotrectinib (larotrectinib sulfate) (VITRAKVI)
- lenvatinib (lenvatinib mesylate) (LENVIMA)
- midostaurin (RYDAPT)
- nintedanib (nintedanib esilate) (OFEV, JAMP NINTEDANIB)
- nintedanib (nintedanib esylate) (AURO-NINTEDANIB)
- pazopanib (pazopanib hydrochloride) (AURO-PAZOPANIB, VOTRIENT, PMS-PAZOPANIB)
- quizartinib (quizartinib hydrochloride) (VANFLYTA)
- regorafenib (STIVARGA)
- ripretinib (QINLOCK)
- selpercatinib (RETEVMO)
- sorafenib (sorafenib tosylate) (NEXAVAR)
- sunitinib (SANDOZ SUNITINIB)
- sunitinib (sunitinib malate) (TARO-SUNITINIB, AURO-SUNITINIB, SUTENT, TEVA-SUNITINIB, NAT-SUNITINIB)
- vandetanib (CAPRELSA)
Using Health Canada Drug Database
updated on 11Apr2026.